Home » Topics » Regulatory

Regulatory
RSS

GSK's Zefix approved in Japan for HBV-associated cirrhosis

Sep. 26, 2005

Remicade now approved in U.S. for ulcerative colitis

Sep. 20, 2005

Increlex approved for short stature caused by severe primary IGF-1 deficiency

Sep. 1, 2005

Actoplus Met approved for type 2 diabetes

Aug. 31, 2005

Taxotere approved for endometrial cancer in Japan

Aug. 24, 2005

Singulair approved for symptoms of perennial allergic rhinitis

Aug. 23, 2005

Diovan approved for high-risk heart attack survivors

Aug. 8, 2005

Celebrex approved for ankylosing spondylitis

Aug. 3, 2005

Japanese approval for Finibax

July 29, 2005

New Adderall XR approval extends use to adolescents

July 26, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...